


Moxtu 7.5mg Tablet
Pay in 3 Installments of
Rs.
138
Description
Moxtu 7.5mg Tablet — Prescription NSAID
Moxtu 7.5mg Tablet is a prescription-only NSAID (Non-Steroidal Anti-Inflammatory Drug) used to treat pain, swelling, and inflammation from arthritis and musculoskeletal conditions. Prescription Required. Available at Derma.pk with valid prescription.
Doctors prescribe Moxtu 7.5mg for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and joint stiffness. It reduces inflammatory mediators to provide targeted pain relief and improve mobility.
Take as directed by your physician, preferably after meals. Not for self-medication. Contact sales@derma.pk or WhatsApp +92-320-5999650 for prescription upload and nationwide delivery.
Usage & Benefits
- Anti-Inflammatory: Reduces prostaglandin activity to control swelling and pain.
- Joint Pain Relief: Effective for arthritis and chronic musculoskeletal pain.
- Improved Mobility: Reduces stiffness to restore comfortable movement.
- Prescription-Grade Relief: Clinically recommended for inflammatory joint diseases.
- Dual Action: Analgesic and anti-inflammatory in one tablet.
How To Use
1. Use as directed by your physician.
2. Take one tablet orally with water, preferably after meals.
3. Do not exceed prescribed dose or duration.
4. Avoid alcohol and other NSAIDs concurrently unless advised by doctor.
5. Consult your doctor immediately if you experience stomach pain, dizziness, or unusual symptoms.
FAQs
What is Moxtu 7.5mg used for?
It treats pain and inflammation from arthritis, joint disorders, and musculoskeletal conditions.
Do I need a prescription?
Yes. Moxtu 7.5mg is a prescription-only NSAID available at Derma.pk with a valid prescription.
How should I take it?
As prescribed by your doctor, usually after meals with water.
Is it safe for long-term use?
Long-term use requires regular monitoring by your physician for gastric and renal health.
What are possible side effects?
Stomach upset, dizziness, or fluid retention. Consult your doctor if symptoms persist.
